GLP-1 Receptor Agonists as Treatment of Nondiabetic Ischemic Stroke: A Systematic Review and Meta-Analysis
GLP-1 RA improves functional outcome and reduces infarct volume in preclinical animal stroke models without diabetes. Translating these promising preclinical findings into clinical benefits remains a key challenge and a critical opportunity for future research.
Authors
- Jan Brink Valentin (ORCID: https://orcid.org/0000-0002-8205-7179)
- Christina Kruuse (ORCID: https://orcid.org/0000-0002-4210-0523)
- Julie Brogaard Larsen (ORCID: https://orcid.org/0000-0002-2978-5185)
- Mads Svart (ORCID: https://orcid.org/0000-0002-9574-0612)
- Rolf Ankerlund Blauenfeldt (ORCID: https://orcid.org/0000-0002-4846-9516)
- Kim Ryun Drasbek
- Claus Z. Simonsen (ORCID: https://orcid.org/0000-0003-1363-0266)
- Michael K. Michaelsen
Institutions
- Steno Diabetes Centers (DK)
- Aarhus University (DK)
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- University College Copenhagen (DK)
- Regional Hospital Horsens (DK)
- Aalborg University (DK)
Publication Details
- Journal
- Stroke
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1161/strokeaha.125.053075
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59